Structure Therapeutics Inc. (GPCR)
NASDAQ: GPCR · Real-Time Price · USD
30.10
-2.61 (-7.98%)
At close: Nov 21, 2024, 4:00 PM
31.00
+0.90 (2.99%)
After-hours: Nov 21, 2024, 4:31 PM EST
Structure Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Selling, General & Admin | 46.79 | 32.67 | 16.37 | 8.59 | 3.54 |
| Research & Development | 95.37 | 70.1 | 36.19 | 29.11 | 12.36 |
| Operating Expenses | 142.16 | 102.78 | 52.56 | 37.7 | 15.91 |
| Operating Income | -142.16 | -102.78 | -52.56 | -37.7 | -15.91 |
| Interest Expense | - | - | - | -0.12 | - |
| Interest & Investment Income | 31.47 | 13.39 | 1.26 | - | 0.17 |
| Pretax Income | -110.69 | -89.38 | -51.3 | -37.82 | -15.74 |
| Income Tax Expense | -0.14 | 0.24 | 0.02 | 0.23 | 0.14 |
| Net Income | -110.55 | -89.62 | -51.32 | -38.05 | -15.88 |
| Preferred Dividends & Other Adjustments | - | - | 1.52 | 5.72 | 0.16 |
| Net Income to Common | -110.55 | -89.62 | -52.84 | -43.77 | -16.04 |
| Shares Outstanding (Basic) | 50 | 37 | 3 | 3 | 2 |
| Shares Outstanding (Diluted) | 50 | 37 | 3 | 3 | 2 |
| Shares Change (YoY) | 91.97% | 1049.81% | 17.73% | 30.01% | - |
| EPS (Basic) | -2.22 | -2.44 | -16.54 | -16.13 | -7.68 |
| EPS (Diluted) | -2.22 | -2.44 | -16.54 | -16.13 | -7.68 |
| Free Cash Flow | -104.33 | -81.66 | -46.28 | -33.37 | -14.3 |
| Free Cash Flow Per Share | -2.09 | -2.22 | -14.49 | -12.30 | -6.85 |
| EBITDA | -141.34 | -102.46 | -52.28 | -37.62 | - |
| D&A For EBITDA | 0.82 | 0.32 | 0.28 | 0.07 | - |
| EBIT | -142.16 | -102.78 | -52.56 | -37.7 | -15.91 |
Source: S&P Capital IQ. Standard template.
Financial Sources.